Abstract
Optimal glycaemic control is critical for patients with type 2 diabetes mellitus (T2DM) to prevent long-term complications, such as cardiovascular diseases. However, nonadherence to medication contributes to 46% of inadequate glycaemic control.
Original language | English |
---|---|
Pages (from-to) | 428-431 |
Number of pages | 4 |
Journal | Diabetes, Obesity and Metabolism |
Volume | 27 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2025 |
Keywords
- clinical trial
- dietary intervention
- glycaemic control
- type 2 diabetes